Related Experiment Video
Updated: Jan 31, 2026

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives
Aimee C Hodowanec1, Andreas Pikis1, Takashi E Komatsu1
1Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products, Food and Drug Administration, Silver Spring, MD, USA.
Abstract:
This review summarizes the significant impact of cytomegalovirus (CMV) infection on solid organ and hematopoietic stem cell transplant recipients. A discussion of the various CMV prevention and treatment strategies is provided, including a detailed description of each of the available CMV antiviral drugs.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Coronary Artery Disease IV: Preventive Measures
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Social Cognitive Perspective on Personality

